# Delivery Order #SPE2D326F287H

Pfizer Delivery Order for Lidocaine Injection Vials

**Buyer:** Defense Logistics Agency

**Award Amount:** $100.00
**Ceiling:** $100.00

**Awarded:** July 22, 2026
**Period of Performance:** Jul 22, 2026 - Jul 23, 2026

**Identifier:** SPE2D326F287H
**NAICS:** 325412

This delivery order under the Defense Logistics Agency’s existing indefinite-delivery contract directs Pfizer Inc. to supply lidocaine hydrochloride 2% in 20 mL vials. Pfizer is a pharmaceutical manufacturer and distributor; its parent company is not identified in the available data. The order supports access to injectable medication for government medical needs, with performance in New York. It is linked to a competitively awarded parent contract covering pharmaceutical supplies, although the order-level competition method and solicitation details are not provided. The parent contract is a long-term vehicle for medicines and related medical products. This order has a very short performance window and was scheduled for fulfillment in July 2026. No acquisition program, subcontractor, or other related prior contract information is available beyond the parent contract.

### Description

4572451646!LIDOCAINE HCL 2% VIAL 20ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F287H_9700_SPE2D020D0014_9700)
